This is in part because studies have shown that FLT3 is highly expressed in most acute leukemias, and the internal tandem duplications (ITD) mutation of this gene that occurs in approximately 25% of AML cases, and increase FLT3 expression on malignant cells has been associated with an adverse prognosis (42, 43). This evidence concerns the gene FLT3 and acute leukemia.